[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100370084":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":34,"locations":45,"responsibleParty":183,"collaborators":185,"id":198,"slug":199,"hasResults":200,"nctId":201,"briefTitle":202,"officialTitle":203,"acronym":204,"eligibilityCriteria":205,"healthyVolunteers":200,"sex":206,"minAge":207,"maxAge":208,"enrollmentInfo":209,"targetDuration":33,"studyType":212,"phases":213,"briefSummary":215,"conditions":216,"keywords":222,"overallStatus":48,"whyStopped":33,"lastUpdateSubmitDate":234,"lastUpdatePostDateStruct":235,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":242,"locationsCount":243},{"fullName":5,"class":6},"Frantz Viral Therapeutics, LLC","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Artesunate vaginal insert","EXPERIMENTAL","Participants will receive three 5-day cycles of artesunate vaginal inserts, 200mg\u002Fday, at week 0, week 2, week 4.",[13],"Drug: Artesunate vaginal insert",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo vaginal inserts","PLACEBO_COMPARATOR","Participants will receive three 5-day cycles of placebo vaginal inserts, at week 0, week 2, and week 4.",[19],"Drug: Placebo vaginal insert",[21,29],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Artesunate formulated as vaginal inserts, 200mg",[9],[26,27,28],"Artesunic acid","DHA","artemisinin",{"type":22,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Placebo vaginal insert","Placebo for artesunate vaginal inserts",[15],null,[35,41],{"name":36,"role":37,"phone":38,"phoneExt":39,"email":40},"Mihaela Plesa, BA, CCRP","CONTACT","440-255-1155","100","FVTinfo@frantzgroup.com",{"name":42,"role":37,"phone":43,"phoneExt":33,"email":44},"Ahmad Bayat, MD","(301) 956-2523","ahmadb@amarexcro.com",[46,71,88,116,130,149,172],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Florida Gynecologic Oncology","RECRUITING","Fort Myers","Florida","33905","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-81.84059,26.62168,{"lat":58,"lon":57},[61,65,68],{"name":62,"role":37,"phone":63,"phoneExt":33,"email":64},"Cami Hansen","239-334-6626","cami.hansen25@gmail.com",{"name":66,"role":67,"phone":33,"phoneExt":33,"email":33},"Fadi Abu Shahin, MD","PRINCIPAL_INVESTIGATOR",{"name":69,"role":70,"phone":33,"phoneExt":33,"email":33},"Samith Sandadi, MD","SUB_INVESTIGATOR",{"facility":72,"status":48,"city":73,"state":74,"zip":75,"country":52,"countryCode":53,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"University of Michigan","Ann Arbor","Michigan","48109",{"type":55,"coordinates":77},[78,79],-83.74088,42.27756,{"lat":79,"lon":78},[82,86],{"name":83,"role":37,"phone":84,"phoneExt":33,"email":85},"Mubeenah Syedah","734-998-6349","symubeen@med.umich.edu",{"name":87,"role":67,"phone":33,"phoneExt":33,"email":33},"Diane Harper, MD",{"facility":89,"status":48,"city":90,"state":91,"zip":92,"country":52,"countryCode":53,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Cleveland Clinic Fairview Hospital","Cleveland","Ohio","44111",{"type":55,"coordinates":94},[95,96],-81.69541,41.4995,{"lat":96,"lon":95},[99,103,106,108,110,112,114],{"name":100,"role":37,"phone":101,"phoneExt":33,"email":102},"Donna White","216-445-8090","whited11@ccf.org",{"name":104,"role":37,"phone":101,"phoneExt":33,"email":105},"Megan Park","parkm2@ccf.org",{"name":107,"role":67,"phone":33,"phoneExt":33,"email":33},"Chad Michener, MD",{"name":109,"role":70,"phone":33,"phoneExt":33,"email":33},"Mariam AlHilli, MD",{"name":111,"role":70,"phone":33,"phoneExt":33,"email":33},"Steven Waggonner, MD",{"name":113,"role":70,"phone":33,"phoneExt":33,"email":33},"Robert DeBernardo, MD",{"name":115,"role":70,"phone":33,"phoneExt":33,"email":33},"Roberto Vargas, MD",{"facility":117,"status":48,"city":90,"state":91,"zip":118,"country":52,"countryCode":53,"cosmosGeoPoint":119,"geoPoint":121,"contacts":122},"Cleveland Clinic Foundation","44195",{"type":55,"coordinates":120},[95,96],{"lat":96,"lon":95},[123,124,125,126,127,128,129],{"name":100,"role":37,"phone":101,"phoneExt":33,"email":102},{"name":104,"role":37,"phone":101,"phoneExt":33,"email":105},{"name":107,"role":67,"phone":33,"phoneExt":33,"email":33},{"name":109,"role":70,"phone":33,"phoneExt":33,"email":33},{"name":111,"role":70,"phone":33,"phoneExt":33,"email":33},{"name":113,"role":70,"phone":33,"phoneExt":33,"email":33},{"name":115,"role":70,"phone":33,"phoneExt":33,"email":33},{"facility":131,"status":48,"city":132,"state":91,"zip":133,"country":52,"countryCode":53,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Hillcrest Hospital","Mayfield Heights","44124",{"type":55,"coordinates":135},[136,137],-81.4579,41.51922,{"lat":137,"lon":136},[140,141,142,143,144,145,146,147],{"name":100,"role":37,"phone":101,"phoneExt":33,"email":102},{"name":104,"role":37,"phone":101,"phoneExt":33,"email":105},{"name":107,"role":67,"phone":33,"phoneExt":33,"email":33},{"name":109,"role":70,"phone":33,"phoneExt":33,"email":33},{"name":111,"role":70,"phone":33,"phoneExt":33,"email":33},{"name":113,"role":70,"phone":33,"phoneExt":33,"email":33},{"name":115,"role":70,"phone":33,"phoneExt":33,"email":33},{"name":148,"role":70,"phone":33,"phoneExt":33,"email":33},"Lindsey Beffa, MD",{"facility":150,"status":48,"city":151,"state":152,"zip":153,"country":52,"countryCode":53,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"The Harris Health System (L.B.J Hospital)","Houston","Texas","77026",{"type":55,"coordinates":155},[156,157],-95.36327,29.76328,{"lat":157,"lon":156},[160,164,168,170],{"name":161,"role":37,"phone":162,"phoneExt":33,"email":163},"Jessica Gallegos","713-563-4580","jrgalleg@mdanderson.org",{"name":165,"role":37,"phone":166,"phoneExt":33,"email":167},"Cindy Melendez","713-563-4582","cvmelend@mdanderson.org",{"name":169,"role":67,"phone":33,"phoneExt":33,"email":33},"Andrea Milbourne, MD",{"name":171,"role":70,"phone":33,"phoneExt":33,"email":33},"Kathleen Schmeler, MD",{"facility":173,"status":48,"city":151,"state":152,"zip":174,"country":52,"countryCode":53,"cosmosGeoPoint":175,"geoPoint":177,"contacts":178},"University of Texas, M.D. Anderson","77030",{"type":55,"coordinates":176},[156,157],{"lat":157,"lon":156},[179,180,181,182],{"name":161,"role":37,"phone":162,"phoneExt":33,"email":163},{"name":165,"role":37,"phone":166,"phoneExt":33,"email":167},{"name":169,"role":67,"phone":33,"phoneExt":33,"email":33},{"name":171,"role":70,"phone":33,"phoneExt":33,"email":33},{"type":184,"investigatorFullName":33,"investigatorTitle":33,"investigatorAffiliation":33,"oldNameTitle":33,"oldOrganization":33},"SPONSOR",[186,189,191,194,196,197],{"name":187,"class":188},"Amarex Clinical Research","OTHER",{"name":190,"class":188},"M.D. Anderson Cancer Center",{"name":192,"class":193},"Harris Health System (L.B.J. Hospital)","UNKNOWN",{"name":195,"class":188},"The Cleveland Clinic",{"name":72,"class":188},{"name":47,"class":193},"100370084","phase-2-artesunate-vaginal-inserts-for-the-treatment-of-cervical-intraepithelial-neoplasia-cin23-100370084",false,"NCT04098744","Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2\u002F3)","A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Vaginal Inserts for the Treatment of Patients With Cervical Intraepithelial Neoplasia (CIN2\u002F3)","ART-CIN_IIB","Inclusion Criteria:\n\n* Adult females age ≥ 25 years\n* Capable of informed consent\n* Any HPV genotype detectable by DNA test\u002FHPV genotyping\n* Colposcopically-directed, histologically confirmed tissue diagnosis of cervical high grade squamous intraepithelial lesions (CIN2, CIN3, or CIN2\u002F3)\n* Women of childbearing potential agree to use birth control through week17 of the study.\n* Weight ≥ 50kg\n\nExclusion Criteria:\n\n* Pregnant and nursing women\n* Active autoimmune disease\n* Taking immunosuppressive medication\n* HIV seropositivity\n* Immunocompromised subjects\n* Evidence of concurrent cervical adenocarcinoma in situ\n* Concurrent malignancy except for nonmelanoma skin lesions, because treatment for other cancers have systemic effects","FEMALE","25 Years","100 Years",{"count":210,"type":211},78,"ESTIMATED","INTERVENTIONAL",[214],"PHASE2","This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2\u002F3).",[217,218,219,220,221],"CIN 2\u002F3","HPV Infection","Pre-Cancerous Dysplasia","Cervical Dysplasia","HPV Related Disease",[223,224,225,226,227,228,229,230,28,231,232,233],"treatment study","cancer prevention","non-surgical","HPV related disease","CIN","topical treatment","vaginal inserts","artesunate","non-invasive","high risk HPV","vaginal suppository","2025-09-29",{"date":236,"type":237},"2025-10-02","ACTUAL",{"date":239,"type":237},"2020-09-09",{"date":241,"type":211},"2026-12-31",{"name":5,"class":6},7]